We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > IDRI

News List

IDRI, Duke Vax Institute, 3M Partner on Adjuvant COVID Vax contractpharma
May 11, 2021
Studies show 3M-052/Alum formulation elicits a strong, durable immune response against several strains of coronavirus, including bat coronaviruses.
Amyris and The Infectious Disease Research Institute Enter into Exclusive License for Novel RNA Vaccine Platform, Beginning with COVID-19 Vaccine prnewswire
October 23, 2020
Amyris, Inc., a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural ingredients, announced the signing of a Collaboration Agreement and License Agreement ...
Baylor College and Texas Children’s to advance Covid-19 vaccine pharmaceutical-technology
June 04, 2020
Baylor College of Medicine and Texas Children’s Hospital Center for Vaccine Development have expanded their alliance with Infectious Disease Research Institute (IDRI) to accelerate the development of a Covid-19 vaccine candidate.
iBio Expands COVID-19 Vaccine Collaboration contractpharma
April 14, 2020
Now includes the Infectious Disease Research Institute to help lead pre-clinical development and clinical trial oversight.
GC Pharma, IDRI, MIBR Launch Curevo contractpharma
May 22, 2018
GC Pharma, a South Korean biopharmaceutical company, announced the establishment of Curevo Inc.